WKRC: Local researchers working on a new potential way to treat eye diseases
UC led research may soon have a new kinder, gentler way to treat eye diseases.
UC drug delivery researcher Kevin Li, a professor in the James L. Winkle College of Pharmacy, takes the lead on new research looking for different ways to treat eye diseases such as macular degeneration and diabetic retinopathy. Currently, these diseases are treated with direct eye injections.
In an interview with WKRC, co-researcher Michael Yang, a pediatric ophthalmologist at Cincinnati Children’s Hospital Medical Center, explains how this federally funded study will seek alternatives to current drug delivery methods.
The study is a collaboration between UC, CCHMC and Ohio State University.
Featured image at top of eye. Photo/Victor Freitas/unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Niche ranks UC among best colleges in Ohio
August 25, 2025
The University of Cincinnati stands out as one of Ohio’s top-ranked institutions in Niche’s 2025 Best Colleges list, as reported by The Columbus Dispatch.
UC Blue Ash has a new look as enrollment continues to grow
August 25, 2025
The University of Cincinnati Blue Ash College features newly renovated spaces and an exciting addition to its campus as it welcomes students to the start of the fall semester.
Back to School 2025: UC’s sustained growth
August 25, 2025
The University of Cincinnati will continue to see growth in enrollment as classes begin Monday, Aug. 25, with a projected 54,000 students — a 1.4% increase over last year.